Bioavailability and Metabolism of Bioactive Compounds from Foods

Nutrition in the Prevention and Treatment of Disease

Volumn , Issue , 2013, Pages 407-423

  Neilson, Andrew P ^a   Ferruzzi, Mario G ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885139767     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391884-0.00022-6     Document Type: Chapter

References (128)

1. Hooper L., Kroon P.A., Rimm E.B., Cohn J.S., Harvey I., Le Cornu K.A., et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88:38-50.
2. Herrera E., Jiménez R., Aruoma O.I., Hercberg S., Sánchez-García I., Fraga C. Aspects of antioxidant foods and supplements in health and disease. Nutr. Rev. 2009, 67:S140-S144.
3. Prasad S., Phromnoi K., Yadav V.R., Chaturvedi M.M., Aggarwal B.B. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 2010, 76:1044-1063.
4. Kale A., Gawande S., Kotwal S. Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother. Res. 2008, 22:567-577.
5. Davì G., Santilli F., Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc. Ther. 2010, 28:216-226.
6. Traber M.G., Frei B., Beckman J.S. Vitamin E revisited: do new data validate benefits for chronic disease prevention?. Curr. Opin. Lipidol. 2008, 19:30-38.
7. Vita J.A. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr. 2005, 81:292S-297S.
8. Grassi D., Desideri G., Croce G., Tiberti S., Aggio A., Ferri C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Design 2009, 15:1072-1084.
9. Thomasset S.C., Berry D.P., Garcea G., Marczylo T., Steward W.P., Gescher A.J. Dietary polyphenolic phytochemicals-Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer 2007, 120:451-458.
10. Rao A.V. Carotenoids and human health. Pharmacol. Res. 2007, 55:207-216.
11. Riccioni G. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep 2009, 11:434-439.
12. Rock C.L. Carotenoids and cancer. Carotenoids 2009, Vol. 5:269-286. Birkhauser, Basel.
13. Galli F., Azzi A. Present trends in vitamin E research. Biofactors 2010, 36:33-42.
14. Tucker J.M., Townsend D.M. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed. Pharmacother. 2005, 59:380-387.
15. Thangapazham R., Sharma A., Maheshwari R. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006, 8:E443-E449.
16. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008, 267:133-164.
17. Hatcher H., Planalp R., Cho J., Torti F., Torti S. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008, 65:1631-1652.
18. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79:727-747.
19. Beecher G.R. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J. Nutr. 2003, 133:3248S-3254S.
20. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
21. Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56:317-333.
22. Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 13:572-584.
23. Iwashina T. The structure and distribution of the flavonoids in plants. J. Plant Res 2000, 113:287-299.
24. Pietta P.G. Flavonoids as antioxidants. J. Nat. Prod. 2000, 63:1035-1042.
25. Yao L.H., Jiang Y.M., Shi J., Tomas-Barberan F.A., Datta N., Singanusong R., et al. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59:113-122.
26. Neilson A.P., Hopf A.S., Cooper B.R., Pereira M.A., Bomser J.A., Ferruzzi M.G. Catechin degradation with concurrent formation of homo- and heterocatechin dimers during in vitro digestion. J. Agric. Food Chem. 2007, 55:8941-8949.
27. Neilson A.P., George J.C., Janle E.M., Mattes R.D., Rudolph R., Matusheski N.V., et al. Influence of chocolate matrix composition on cocoa flavan-3-ol bioaccessibility in vitro and bioavailability in humans. J. Agric. Food Chem. 2009, 57:9418-9426.
28. Neilson A.P., Sapper T.N., Janle E.M., Rudolph R., Matusheski N.V., Ferruzzi M.G. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats. J. Agric. Food Chem. 2010, 58:6685-6691.
29. Crespy V., Morand C., Besson C., Cotelle N., Vezin H., Demigne C., et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G980-G988.
30. Lambert J.D., Sang S.M., Yang C.S. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm. 2007, 4:819-825.
31. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Therap 2003, 307:745-752.
32. Silberberg M., Morand C., Manach C., Scalbert A., Remesy C. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci. 2005, 77:3156-3167.
33. Feng W.Y. Metabolism of green tea catechins: an overview. Curr. Drug Metab. 2006, 7:755-809.
34. Takano M., Yumoto R., Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 2006, 109:137-161.
35. Williamson G., Day A.J., Plumb G.W., Couteau D. Human metabolic pathways of dietary flavonoids and cinnamates. Biochem. Soc. Trans. 2000, 28:16-22.
36. Hackman R., Polagruto J., Zhu Q., Sun B., Fujii H., Keen C. Flavanols: Digestion, absorption and bioactivity. Phytochem. Rev 2008, 7:195-208.
37. Piskula M.K., Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr 1998, 128:1172-1178.
38. Chan L.M.S., Lowes S., Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 2004, 21:25-51.
39. Hu C., Kitts D.D. Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro. Mol. Cell. Biochem. 2001, 218:147-155.
40. Vaidyanathan J.B., Walle T. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res 2001, 18:1420-1425.
41. Kohri T., Matsumoto N., Yamakawa M., Suzuki M., Nanjo F., Hara Y., et al. Metabolic fate of (-)-[4-3H]epigallocatechin gallate in rats after oral administration. J. Agric. Food Chem. 2001, 49:4102-4112.
42. Zhu B.T., Patel U.K., Cai M.X., Lee A.J., Conney A.H. Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica 2001, 31:879-890.
43. Abrahamse S.L., Kloots W.J., van Amelsvoort J.M.M. Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Nutr. Res. 2005, 25:305-317.
44. Lambert J.D., Lee M.J., Lu H., Meng X.F., Ju J., Hong J., et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 2003, 133:4172-4177.
45. Yang B., Arai K., Kusu F. Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection. Anal. Biochem 2000, 283:77-82.
46. Kohri T., Suzuki M., Nanjo F. Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 2003, 51:5561-5566.
47. Yang C.S., Chen L.S., Lee M.J., Balentine D., Kuo M.C., Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev 1998, 7:351-354.
48. Harada M., Kan Y., Naoki H., Fukui Y., Kageyama N., Nakai M., et al. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci. Biotechnol. Biochem. 1999, 63:973-977.
49. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81:230S-242S.
50. Mai V., Morris J.G. Colonic bacterial flora: changing understandings in the molecular age. J. Nutr. 2004, 134:459-464.
51. Duncan S.H., Louis P., Flint H.J. Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 2007, 44:343-350.
52. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006, 7:688-693.
53. Roberfroid M.B., Bornet F., Bouley C., Cummings J.H. Colonic microflora: Nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr. Rev. 1995, 53:127-130.
54. Guarner F., Malagelada J.-R. Gut flora in health and disease. Lancet 2003, 361:512-519.
55. Donovan J.L., Manach C., Rios L., Morand C., Scalbert A., Remesy C. Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B-3. Br. J. Nutr. 2002, 87:299-306.
56. Donovan J.L., Kasim-Karakas S., German J.B., Waterhouse A.L. Urinary excretion of catechin metabolites by human subjects after red wine consumption. Br. J. Nutr. 2002, 87:31-37.
57. Lee M.J., Maliakal P., Chen L.S., Meng X.F., Bondoc F.Y., Prabhu S., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev 2002, 11:1025-1032.
58. Henning S.M., Niu Y.T., Lee N.H., Thames G.D., Minutti R.R., Wang H.J., et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80:1558-1564.
59. Auger C., Mullen W., Hara Y., Crozier A. Bioavailability of poluphenon E flavan-3-ols in humans with an ileostomy. J. Nutr. 2008, 138:1535-1542.
60. Baba S., Osakabe N., Natsume M., Terao J. Absorption and urinary excretion of procyanidin B2 epicatechin-(4 beta-8)-epicatechin in rats. Free Radic. Biol. Med. 2002, 33:142-148.
61. Tsang C., Auger C., Mullen W., Bornet A., Rouanet J.M., Crozier A., et al. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr. 2005, 94:170-181.
62. Appeldoorn M.M., Vincken J.P., Gruppen H., Hollman P.C.H. Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J. Nutr. 2009, 139:1469-1473.
63. Shoji T., Masumoto S., Moriichi N., Akiyama H., Kanda T., Ohtake Y., et al. Apple procyanidin oligomers absorption in rats after oral administration: Analysis of procyanidins in plasma using the Porter method and high-performance liquid chromatography/tandem mass spectrometry. J. Agric. Food Chem 2006, 54:884-892.
64. Holt R.R., Lazarus S.A., Sullards M.C., Zhu Q.Y., Schramm D.D., Hammerstone J.F., et al. Procyanidin dimer B2 epicatechin-(4 beta-8)-epicatechin in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 2002, 76:798-804.
65. Kohri T., Suzuki M., Nanjo F. Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 2003, 51:5561-5566.
66. Kohri T., Nanjo F., Suziki M., Seto R., Matsumoto N., Yamakawa M., et al. Synthesis of (-)-4-H-3 epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J. Agric. Food Chem. 2001, 49:1042-1048.
67. Justesen U., Arrigoni E., Larsen B.R., Amado R. Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensmittel-Wissenschaft Technol 2000, 33:424-430.
68. Simons A.L., Renouf M., Hendrich S., Murphy P.A. Human gut microbial degradation of flavonoids: Structure-function relationships. J. Agric. Food Chem. 2005, 53:4258-4263.
69. Das N.P., Griffith L.A. Studies on flavonoid metabolism: Metabolism of (+)-catechin in guinea pig. Biochem. J. 1968, 110:449.
70. Das N.P., Griffith L.A. Studies on flavonoid metabolism: Metabolism of (+)-14C catechin in rat and guinea pig. Biochem. J. 1969, 115:831.
71. Winter J., Moore L.H., Dowell V.R., Bokkenheuser V.D. C-ring cleavage of flavonoids by human intestinal bacteria. Appl. Environ. Microbiol. 1989, 55:1203-1208.
72. Bravo L., Abia R., Eastwood M.A., Sauracalixto F. Degradation of polyphenols (catechin and tannic-acid) in the rat intestinal tract: effect on colonic fermentation and fecal output. Br. J. Nutr. 1994, 71:933-946.
73. Tzounis X., Vulevic J., Kuhnle G.G.C., George T., Leonczak J., Gibson G.R., et al. Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 2008, 99(782-792).
74. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157:876-884.
75. Gonthier M.P., Cheynier V., Donovan J.L., Manach C., Morand C., Mila I., et al. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 2003, 133:461-467.
76. Lin Y.-T., Hsiu S.-L., Hou Y.-C., Chen H.-Y., Chao P.-D.L. Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. Biol. Pharm. Bull. 2003, 26:747-751.
77. Rios L.Y., Gonthier M.-P., Remesy C., Mila I., Lapierre C., Lazarus S.A., et al. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 2003, 77:912-918.
78. Gao K., Xu A., Krul C., Venema K., Liu Y., Niu Y., et al. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 2006, 136:52-57.
79. Abia R., Fry S.C. Degradation and metabolism of C-14-labelled proanthocyanidins from carob (Ceratonia siliqua) pods in the gastrointestinal tract of the rat. J. Sci. Food Agric 2001, 81:1156-1165.
80. Veeriah S., Hofmann T., Glei M., Dietrich H., Will F., Schreier P., et al. Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29). J. Agric. Food Chem. 2007, 55:2892-2900.
81. Urpi-Sarda M., Monagas M., Khan N., Lamuela-Raventos R.M., Santos-Buelga C., Sacanella E., et al. Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Anal. Bioanal. Chem. 2009, 394:1545-1556.
82. Gonthier M.P., Donovan J.L., Texier O., Felgines C., Remesy C., Scalbert A. Metabolism of dietary procyanidins in rats. Free Radic. Biol. Med. 2003, 35:837-844.
83. Aura A.M., Mattila I., Seppanen-Laakso T., Miettinen J., Oksman-Caldentey K.M., Oresic M. Microbial metabolism of catechin stereoisomers by human faecal microbiota: comparison of targeted analysis and a non-targeted metabolomics method. Phytochem. Lett 2008, 1:18-22.
84. Deprez S., Brezillon C., Rabot S., Philippe C., Mila I., Lapierre C., et al. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 2000, 130:2733-2738.
85. Kahle K., Huemmer W., Kempf M., Scheppach W., Erk T., Richling E. Polyphenols are intensively metabolized in the human gastrointestinal tract after apple juice consumption. J. Agric. Food Chem. 2007, 55:10605-10614.
86. Stoupi S., Williamson G., Drynan J.W., Barron D., Clifford M.N. Procyanidin B2 catabolism by human fecal microflora: partial characterization of "dimeric" intermediates. Arch. Biochem. Biophys. 2010, 501:73-78.
87. Stoupi S., Williamson G., Drynan J.W., Barron D., Clifford M.N. A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota. Mol. Nutr. Food Res. 2009, 54:747-759.
88. van't Slot G., Humpf H.-U. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model. J. Agric. Food Chem 2009, 57:8041-8048.
89. Sharma M., Li L., Celver J., Killian C., Kovoor A., Seeram N.P. Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J. Agric. Food Chem. 2009, 58:3965-3969.
90. Kasimsetty S.G., Bialonska D., Reddy M.K., Ma G., Khan S.I., Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. 2010, 58:2180-2187.
91. Gonzalez-Sarrias A., Larrosa M., Tomas-Barberan F.A., Dolara P., Espin J.C. NF-kB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr. 2010, 104:503-512.
92. Bialonska D., Kasimsetty S.G., Khan S.I., Ferreira D. Urolithins, intestinal microbial metabolites of pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J. Agric. Food Chem. 2009, 57:10181-10186.
93. Larrosa M., González-Sarrías A., Yáñez-Gascón M.J., Selma M.V., Azorín-Ortuño M., Toti S., et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem. 2010, 21:717-725.
94. Lu S., Li L. Carotenoid metabolism: Biosynthesis, regulation, and beyond. J. Integrative Plant Biol. 2008, 50:778-785.
95. Castenmiller J.J.M., West C.E. Bioavailability and bioconversion of carotenoids. Annu. Rev. Nutr. 1998, 18:19-38.
96. DellaPenna D., Pogson B.J. Vitamin synthesis in plants: Tocopherols and carotenoids. Annu. Rev. Plant Biol. 2006, 57:711-738.
97. Sen C.K., Khanna S., Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006, 78:2088-2098.
98. Colombo M.L. An update on vitamin E, tocopherol and tocotrienol: Perspectives. Molecules 2010, 15:2103-2113.
99. Schneider C. Chemistry and biology of vitamin E. Mol. Nutr. Food Res. 2005, 49:7-30.
100. Fernandez-Garcia E., Carvajal-Lerida I., Jaren-Galan M., Garrido-Fernandez J., Perez-Galvez A., Hornero-Mendez D. Carotenoids bioavailability from foods: from plant pigments to efficient biological activities. Food Res. Int. 2012, 46:438-450.
101. Goltz S., Ferruzzi M.G. Factors affecting carotenoid bioavailability: Dietary fat and fiber. Carotenoids and Human Health 2012, Spinger, New York. S. Tanumihardjo (Ed.).
102. Kotake-Nara E., Nagao A. Absorption and metabolism of xanthophylls. Marine Drugs 2011, 9:1024-1037.
103. Harrison E.H. Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochim. Biophys. Acta 2012, 1821:70-77.
104. Brown M.J., Ferruzzi M.G., Nguyen M.L., Cooper D.A., Eldridge A.L., Schwartz S.J., et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am. J. Clin. Nutr. 2004, 80:396-403.
105. Reboul E., Richelle M., Perrot E.Ø., Desmoulins-Malezet C., Pirisi V., Borel P. Bioaccessibility of carotenoids and vitamin E from their main dietary sources. J. Agric. Food Chem. 2006, 54:8749-8755.
106. Huo T., Ferruzzi M.G., Schwartz S.J., Failla M.L. Impact of fatty acyl composition and quantity of triglycerides on bioaccessibility of dietary carotenoids. J. Agric. Food Chem. 2007, 55:8950-8957.
107. Kean E.G., Hamaker B.R., Ferruzzi M.G. Carotenoid bioaccessibility from whole grain and degermed maize meal products. J. Agric. Food Chem. 2008, 56:9918-9926.
108. Kohut A.R., Failla M.L., Watkins B.A., Ferruzzi M.G. The impact of lipid quantity and type on carotenoid bioaccessibility from vegetables. FASEB J. 2007, 21:A350.
109. Ferruzzi M.G., Lumpkin J.L., Schwartz S.J., Failla M. Digestive stability, micellarization, and uptake of beta-carotene isomers by Caco-2 human intestinal cells. J. Agric. Food Chem. 2006, 54:2780-2785.
110. Huo T.Y., Ferruzzi M.G., Belury M.A., Schwartz S.J., Failla M.L. Impact of amount and triglyceride (TG) structure on micellarization of dietary carotenoids during simulated digestion. FASEB J. 2007, 21:A730-A731.
111. Anwar K., Iqbal J., Hussain M.M. Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J. Lipid Res. 2007, 48:2028-2038.
112. Iqbal J., Hussain M.M. Intestinal lipid absorption. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1183-E1194.
113. Rigotti A. Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 2007, 28:423-436.
114. Brisson L., Castan S., Fontbonne H., Nicoletti C., Puigserver A., Ajandouz E.H. Alpha-tocopheryl acetate is absorbed and hydrolyzed by Caco-2 cells: comparative studies with alpha-tocopherol. Chem. Phys. Lipids 2008, 154:33-37.
115. Wajda R., Zirkel J., Schaffer T. Increase of bioavailability of coenzyme Q(10) and vitamin E. J. Medicinal Food 2007, 10:731-734.
116. O'Callaghan Y., O'Brien N. Bioaccessibility, cellular uptake and transepithelial transport of alpha-tocopherol and retinol from a range of supplemented foodstuffs assessed using the caco-2 cell model. Int. J. Food Sci. Technol. 2010, 45:1436-1442.
117. Reboul E., Borel P. Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 2011, 50:388-402.
118. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
119. Shehzad A., Wahid F., Lee Y.S. Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch. Pharmazie 2010, 343:489-499.
120. Hamaguchi T., Ono K., Yamada M. Review: Curcumin and Alzheimer's disease. CNS Neurosci. Ther. 2010, 16:285-297.
121. Bisht S., Maitra A. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 2009, 6:192-199.
122. Ireson C.R., Jones D.J.L., Orr S., Coughtrie M.W.H., Boocock D.J., Williams M.L., et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 2002, 11:105-111.
123. Sharma R.A., Steward W.P., Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 2007, 595:453-470.
124. Burgos-Morón E., Calderón-Montaño J.M., Salvador J., Robles A., López-Lázaro M. The dark side of curcumin. Int. J. Cancer 2010, 126:1771-1775.
125. Kurien B.T., Scofield R.H. Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals. Int. J. Cancer 2009, 125:1992-1993.
126. Shaikh J., Ankola D.D., Beniwal V., Singh D., Kumar M.N.V.R. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 2009, 37:223-230.
127. Kang M.J., Cho J.Y., Shim B.H., Kim D.K., Lee J. Bioavailability enhancing activities of natural compounds from medicinal plants. J. Med. Plants Res. 2009, 3:1204-1211.
128. Khajuria A., Thusu N., Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002, 9:224-230.